Predictors of survival in paediatric mitral valve replacement

Gianluca Brancaccio1, Matteo Trezzi1, Marcello Chinali2

  • 1Department of Pediatric Cardiac Surgery, Bambino Gesù Children's Hospital, Rome, Italy.

Insights

Mitral valve replacement (MVR) in children is effective, with mortality predicted by prosthesis size/weight ratio and age under 2 years. Re-replacement is feasible, allowing for larger valve implantation.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Congenital or acquired mitral valve disease in children often necessitates surgical intervention.
  • Mitral valve replacement (MVR) is a critical procedure for managing unrepairable mitral valve disease in pediatric patients.
  • Predicting outcomes and identifying risk factors for MVR in children is essential for optimizing patient care.

Purpose of the Study:

  • To identify predictors of mortality and reintervention following MVR in pediatric patients.
  • To assess the long-term efficacy and safety of MVR in children.
  • To evaluate the feasibility of mitral valve re-replacement in pediatric cases.

Main Methods:

  • A retrospective single-center study included 115 pediatric patients (<18 years) who underwent MVR between 1982 and 2019.
  • Calculated the ratio of prosthetic valve size to patient weight (mm/kg) at surgery.
  • Assessed long-term outcomes including freedom from re-replacement and death/transplant-free survival.

Main Results:

  • Death/transplant-free survival was 77±4% at 5 years and 72±5% at 10 years.
  • A size/weight ratio >2 and age <2 years were significant risk factors for death or transplant.
  • Biological prosthesis and a size/weight ratio >2 predicted reoperation; significant prosthesis upsizing was noted at re-replacement.

Conclusions:

  • Mitral valve replacement is a viable strategy for children with severe mitral valve disease.
  • Prosthesis size/weight ratio and early childhood age (<2 years) are key predictors of mortality after MVR.
  • Mitral valve re-replacement in children can be performed with acceptable morbidity and mortality, often accommodating larger prostheses.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
162
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
154
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
109
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
127
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
189
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
128